News and Views

Cancer screening

Testicular Cancer Survivors May Need Fewer Monitoring Scans

Monitoring early-stage testicular cancer survivors for disease recurrence after surgery using either magnetic resonance imaging or fewer computed tomography scans is just as effective as more frequent intervals, researchers reported in study findings published in the Journal of Clinical Oncology.

September 21, 2022

Trending Topics

View All Topics

FDA Approves Selpercatinib for RET Fusion-Positive Non-Small Cell Lung Cancer and Locally Advanced or Metastatic Solid Tumors

U.S. Food and Drug Administration (FDA)

FDA Approves Selpercatinib for RET Fusion-Positive Non-Small Cell Lung Cancer and Locally Advanced or Metastatic Solid Tumors

September 23, 2022

FDA Approves Sodium Thiosulfate for Cisplatin-Associated Ototoxicity n Pediatric Patients

U.S. Food and Drug Administration (FDA)

FDA Approves Sodium Thiosulfate for Cisplatin-Associated Ototoxicity in Pediatric Patients

September 22, 2022

Balance Hope and Quality of Life for Phase I Clinical Trials

Oncology clinical trials

Balance Hope and Quality of Life for Phase I Clinical Trials

September 20, 2022

Share Your Best Practices and Other Oncology Nursing Experiences Through an ONS Voice Article or Video

Clinical practice

Share Your Best Practices and Other Oncology Nursing Experiences Through an ONS Voice Article or Video

September 19, 2022

Baxter Healthcare Corporation Recalls Clearlink Basic Solution Set With Duovent Because of Leaks That Risk Exposure to Toxic Substances

U.S. Food and Drug Administration (FDA)

Baxter Healthcare Corporation Recalls Clearlink Basic Solution Set With Duovent Because of Leaks That Risk Exposure to Toxic Substances

September 16, 2022

Help Caregivers Control the Chronic Stress of Cancer Care and Manage PTSD

Caregiver support

Help Caregivers Control the Chronic Stress of Cancer Care and Manage PTSD

September 15, 2022

Oncology Nurses’ Role in Translating Biomarker Testing Results

Genetics & genomics

Oncology Nurses’ Role in Translating Biomarker Testing Results

September 15, 2022

Biden Announces Progress on Cancer Moonshot Initiative, Meets With ONS President

Cancer moonshot

Biden Announces Progress on Cancer Moonshot Initiative, Meets With ONS President

September 14, 2022

Certain Cancers May Increase Risk of Type 2 Diabetes

Certain Cancers May Increase Risk of Type 2 Diabetes

September 14, 2022

Nurse Scientists Are Leading Patient Care Discoveries in the Ever-Evolving World of Cancer Survivorship

Nurse Scientists Are Leading Patient Care Discoveries in the Ever-Evolving World of Cancer Survivorship

September 13, 2022

Low Cost-Related Health Literacy May Prevent Survivors From Following Care Plans

Cancer health disparities

Low Cost-Related Health Literacy May Prevent Survivors From Following Care Plans

September 13, 2022

FDA Reports Squamous Cell Carcinoma and Various Lymphomas in Capsule Around Breast Implants

U.S. Food and Drug Administration (FDA)

FDA Reports Squamous Cell Carcinoma and Various Lymphomas in Capsule Around Breast Implants

September 12, 2022

APRNs Collaborate With PCPs on Shared Survivorship Care Models

Advanced Practice Nursing (APRN)

APRNs Collaborate With PCPs on Shared Survivorship Care Models

September 08, 2022

FDA Approves Durvalumab for Locally Advanced or Metastatic Biliary Tract Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves Durvalumab for Locally Advanced or Metastatic Biliary Tract Cancer

September 07, 2022

Drug Clinical Trials Focus on Efficacy Over Quality of Life

Oncology clinical trials

Drug Clinical Trials Focus on Efficacy Over Quality of Life

September 07, 2022

Data Coordinators and Oncology Nurses Collaborate to Create Accurate, Comprehensive Survivorship Care Plans

Survivorship care plans

Data Coordinators and Oncology Nurses Collaborate to Create Accurate, Comprehensive Survivorship Care Plans

September 06, 2022

Nurse-Led Survivorship Programs

Nurse-Led Survivorship Programs

September 06, 2022

Have Hope for the Next Generation of Oncology Nurses

Have Hope for the Next Generation of Oncology Nurses

September 05, 2022

$FDA Approves Pemigatinib for Relapsed or Refractory Myeloid or Lymphoid Neoplasms With FGFR1 Rearrangement$

U.S. Food and Drug Administration (FDA)

FDA Approves Pemigatinib for Relapsed or Refractory Myeloid or Lymphoid Neoplasms With FGFR1 Rearrangement

August 30, 2022

Intera Oncology Recalls Intera 3000 Hepatic Artery Infusion Pump Because of Faster-Than-Expected Flow Rates

U.S. Food and Drug Administration (FDA)

Intera Oncology Recalls Intera 3000 Hepatic Artery Infusion Pump Because of Faster-Than-Expected Flow Rates

August 30, 2022

Social and Community Context Matter in Cancer Care

Patient Support

Social and Community Context Matter in Cancer Care

August 30, 2022

International Search Finds Inspiring Young Leaders for New Pilot Program

Inspiring, Diverse Nurses Join ONS's Young Leaders Pilot Program

August 25, 2022

FDA Approves Ibrutinib for Pediatric Patients With Chronic Graft-Versus-Host Disease, Including a New Oral Suspension

U.S. Food and Drug Administration (FDA)

FDA Approves Ibrutinib for Pediatric Patients With Chronic Graft-Versus-Host Disease, Including a New Oral Suspension

August 25, 2022

Vision Boards Turn Your Dreams Into Reality

Nurse well-being

Vision Boards Turn Your Dreams Into Reality

August 25, 2022

Dietary-Produced Ketone May Halt Colon Cancer

Cancer research

Dietary-Produced Ketone May Halt Colon Cancer

August 24, 2022

Oncology Drug Reference Sheet: Nivolumab and Relatlimab-Rmbw

Drug Reference Sheet

Oncology Drug Reference Sheet: Nivolumab and Relatlimab-Rmbw

August 23, 2022

American Academy of Nursing Inducts Three ONS Members as 2022 Fellows

American Academy of Nursing Inducts Three ONS Members as 2022 Fellows

August 22, 2022

As Skin Cancer Screening Increases, Clinicians Find More Thin Melanomas

Cancer screening

As Skin Cancer Screening Increases, Clinicians Find More Thin Melanomas

August 17, 2022

Nearly half of patients with brain cancer have limited MDC at diagnosis, and most patients will experience some neurocognitive decline over time. Current ethical parameters maintain that patients must be able to understand the risks and benefits of a treatment and assume personal accountability for their choice. However, providers have no gold standard tool designed to assess a patient’s MDC, and clinicians often make implicit judgement regarding patients’ MDC. If an MDC assessment tool is used, the results

Patient Support

Support Impaired Patients’ Medical Decision-Making Capacity

August 16, 2022

FDA Grants Accelerated Approval to Fam-Trastuzumab Deruxtecan-Nxki for HER2-Variant Non-Small Cell Lung Cancer

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Fam-Trastuzumab Deruxtecan-Nxki for HER2-Variant Non-Small Cell Lung Cancer

August 15, 2022

FDA Approves Capmatinib for Metastatic Non-Small Cell Lung Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves Capmatinib for Metastatic Non-Small Cell Lung Cancer

August 15, 2022

New Technology Tools Help Oncology APRNs Improve Patient Outcomes

Advanced Practice Nursing (APRN)

New Technology Tools Help Oncology APRNs Improve Patient Outcomes

August 11, 2022

Monkeypox Fact Sheet and Implications for Patients With Cancer

Nursing education

Monkeypox Fact Sheet and Implications for Patients With Cancer

August 10, 2022

Single HPV Vaccine Dose May Be Enough to Prevent Cancer

Cancer research

Single HPV Vaccine Dose May Be Enough to Prevent Cancer

August 10, 2022

Nurses Are Pivotal to Advancing Biden’s Cancer Moonshot Initiative

Cancer health policy

Nurses Are Pivotal to Advancing Biden’s Cancer Moonshot Initiative

August 09, 2022

Promote Patient Self-Advocacy Across the Cancer Spectrum

Patient advocacy

Promote Patient Self-Advocacy Across the Cancer Spectrum

August 09, 2022

FDA Approves Darolutamide Tablets for Metastatic Hormone-Sensitive Prostate Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves Darolutamide Tablets for Metastatic Hormone-Sensitive Prostate Cancer

August 08, 2022

FDA Approves Fam-Trastuzumab Deruxtecan-Nxki for HER2-Low Breast Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves Fam-Trastuzumab Deruxtecan-Nxki for HER2-Low Breast Cancer

August 08, 2022

Genetic Disorder Reference Sheet: Multiple Endocrine Neoplasia Type 2

Genetics & genomics

Genetic Disorder Reference Sheet: Multiple Endocrine Neoplasia Type 2

August 04, 2022

Cancer Mortality Declines Among Black Patients but Remains Disproportionately High

Cancer health disparities

Cancer Mortality Declines Among Black Patients but Remains Disproportionately High

August 03, 2022

When Healthcare Professionals Join Organizations to Advocate, Patients’ Voices Are Heard

Cancer risk prevention

When Healthcare Professionals Join Organizations to Advocate, Patients’ Voices Are Heard

August 02, 2022

Legislation and Cancer Care

Cancer health policy

Legislation and Cancer Care

August 02, 2022

Your ONS Membership Offers You Benefits in Other Organizations, Too

Your ONS Membership Offers You Benefits in Other Organizations, Too

August 01, 2022

FDA Reports Recall of CVS Magnesium Citrate Saline Laxative Oral Solution Lemon Flavor Due to Microbial Contamination

U.S. Food and Drug Administration (FDA)

FDA Reports Recall of CVS Magnesium Citrate Saline Laxative Oral Solution Lemon Flavor Due to Microbial Contamination

Use This Checklist to Take a Stress-Free Vacation

Nurse well-being

Use This Checklist to Take a Stress-Free Vacation

Wildfire Pollutants Increase Risk of Lung, Brain Tumors

Cancer research

Wildfire Pollutants Increase Risk of Lung, Brain Tumors

Baxter Healthcare Corporation Recalls Abacus Software for Risk of Medication Label Errors

U.S. Food and Drug Administration (FDA)

Baxter Healthcare Corporation Recalls Abacus Software for Risk of Medication Label Errors

Oncology Drug Reference Sheet: Lutetium Lu 177 Vipivotide Tetraxetan

Drug Reference Sheet

Oncology Drug Reference Sheet: Lutetium Lu 177 Vipivotide Tetraxetan

Smiths Medical Recalls Medfusion 3500 and 4000 Syringe Infusion Pumps for Software Malfunctions That Can Affect Infusion Delivery

U.S. Food and Drug Administration (FDA)

Smiths Medical Recalls Medfusion 3500 and 4000 Syringe Infusion Pumps for Software Malfunctions That Can Affect Infusion Delivery

Back to Top ▲